» Articles » PMID: 28827043

Nivolumab-associated Nausea and Vomiting As an Immune Adverse Event

Overview
Journal Eur J Cancer
Specialty Oncology
Date 2017 Aug 23
PMID 28827043
Citations 7
Authors
Affiliations
Soon will be listed here.
Citing Articles

Open-capsule budesonide for the treatment of immune-related enteritis from checkpoint inhibitors.

Magahis P, Corso T, Livingstone P, Tom E, Srivastava A, Postow M J Immunother Cancer. 2024; 12(7).

PMID: 39032941 PMC: 11261704. DOI: 10.1136/jitc-2024-009051.


Upper gastrointestinal tract immune-related adverse events: Two cases of obstructive complications occurred in immune consolidation therapy after sequential chimeric antigen receptor T cell therapy with autologous hematopoietic stem cell....

Zhang Q, Li C, Cao Y, Wang N, Huang L, Shang Z Clin Case Rep. 2024; 12(1):e8411.

PMID: 38235413 PMC: 10792699. DOI: 10.1002/ccr3.8411.


Nivolumab-induced tumour-like gastritis: A case report.

Cijauskaite E, Kazenaite E, Strainiene S, Sadauskaite G, Kurlinkus B World J Clin Cases. 2023; 11(18):4350-4359.

PMID: 37449232 PMC: 10336988. DOI: 10.12998/wjcc.v11.i18.4350.


Spontaneous bacterial peritonitis in hepatocellular carcinoma after PD-1 inhibitor therapy: two clinical cases.

Liu J, Xue H, Bai S, Wang J, Zhang Y, Liu L Heliyon. 2022; 8(11):e11248.

PMID: 36387537 PMC: 9649979. DOI: 10.1016/j.heliyon.2022.e11248.


Upper Gastrointestinal Tract IrAEs: A Case Report About Sintilimab-Induced Acute Erosive Hemorrhagic Gastritis.

Ai Q, Chen W, Li Y, Li G Front Immunol. 2022; 13:840916.

PMID: 35720298 PMC: 9204206. DOI: 10.3389/fimmu.2022.840916.